Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings

OBJECTIVES: Our objectives were to investigate the cost effectiveness of apixaban, rivaroxaban, and dabigatran compared with coumarin derivatives for stroke prevention in patients with atrial fibrillation in a country with specialized anticoagulation clinics (the Netherlands) and in a country withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoef, Talitha I., Redekop, William K., Hasrat, Fazila, de Boer, Anthonius, Maitland-van der Zee, Anke Hilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250561/
https://www.ncbi.nlm.nih.gov/pubmed/25326294
http://dx.doi.org/10.1007/s40256-014-0092-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250561/
https://www.ncbi.nlm.nih.gov/pubmed/25326294
http://dx.doi.org/10.1007/s40256-014-0092-1

Ejemplares similares